Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03829761 · ClinicalTrials.gov registry record · NA
Cerebellar Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Alcohol Use Disorder
A NA study, sponsored by The Mind Research Network.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT03829761: Completed NA study, sponsored by The Mind Research Network.
NCT03829761 is a NA study that has completed, run by The Mind Research Network. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03829761, a NA study, has completed, sponsored by The Mind Research Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The objective of the current study is to investigate the effects of repetitive transcranial magnetic stimulation (rTMS) on self-reported negative affect, cerebellar brain activation and alcohol use outcomes in alcohol use disorder (AUD).
Primary Outcome
Time to drinking relapse as measured by the Time Line Follow Back from baseline in days.
Interventions
- DEVICE Repetitive transcranial magnetic stimulation (rTMS)
- DEVICE Sham transcranial magnetic stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2019-02-20 |
| Est. Completion | 2023-09-07 |
| Phase | NA |
What the finished NCT03829761 record still lists
NCT03829761 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Repetitive transcranial magnetic stimulation (rTMS) is the first listed.
NCT03829761 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03829761 about?
NCT03829761 is a clinical study titled "Cerebellar Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Alcohol Use Disorder". The objective of the current study is to investigate the effects of repetitive transcranial magnetic stimulation (rTMS) on self-reported negative affect, cerebellar brain activation and alcohol use outcomes in alcohol use disorder (AUD).
What is the current status of trial NCT03829761?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2019-02-20. Estimated completion is 2023-09-07.
What interventions are being tested in trial NCT03829761?
The interventions under investigation include: Repetitive transcranial magnetic stimulation (rTMS) (DEVICE), Sham transcranial magnetic stimulation (DEVICE).
Who is sponsoring clinical trial NCT03829761?
This trial is sponsored by The Mind Research Network, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03829761's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI